Yuanyi Chen
Overview
Explore the profile of Yuanyi Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
119
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao H, Luo D, Feng A, Zhou X, Lin Y, Chen Y, et al.
BMC Infect Dis
. 2025 Mar;
25(1):343.
PMID: 40069637
Background: The association between Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways and immunologic non-response among people living with HIV (PLHIV) on antiretroviral therapy (ART) is not well documented....
2.
Wu X, Wang Z, Li B, Zhang W, Chen Y, Wu G, et al.
Sex Health
. 2025 Feb;
22.
PMID: 39946225
Background China implemented extensive non-pharmaceutical interventions (NPIs) to contain COVID-19. Methods National and provincial data on monthly reported HIV and AIDS cases from January 2017 to December 2020 were collected...
3.
Wu X, Chen Y, Lu Z, Wang J, Zou H
BMJ Open
. 2024 Aug;
14(8):e081129.
PMID: 39181549
Introduction: Despite the favourable efficacy of antiretroviral therapy (ART), HIV/AIDS continues to impose significant disease burdens worldwide. This study aims to systematically review published prognostic prediction models for survival outcomes...
4.
Zhang W, Qi X, Han B, Fu L, Wang B, Wu K, et al.
Public Health
. 2024 Aug;
236:115-124.
PMID: 39180937
Objectives: Mpox continues to spread in China, and stakeholders' experiences may help inform prevention and control strategies. Study Design: Qualitative study. Methods: A qualitative study across 14 Chinese cities recruited...
5.
Wu X, Zhou X, Chen Y, Lin Y, Li Y, Fu L, et al.
Sex Health
. 2024 Aug;
21.
PMID: 39146461
Background Sexual transmission accounts for a substantial proportion of HIV infections. Although some countries are experiencing an upward trend in HIV infections, there has been a lack of studies assessing...
6.
Song J, Huan X, Chen Y, Luo Y, Zhong H, Wang Y, et al.
Ther Adv Neurol Disord
. 2024 Jul;
17:17562864241261602.
PMID: 39072008
Eculizumab has improved recovery from ventilatory support in myasthenic crisis (MC) cases. However, the safety and efficacy profiles from prospective studies are still lacking. This study aimed to explore eculizumab's...
7.
Bian J, Zhang W, Guo Z, Li X, Fu L, Lu Z, et al.
Nat Aging
. 2024 May;
4(5):638-646.
PMID: 38724731
The uptake of COVID-19 booster vaccination among older adults in China is suboptimal. Here, we report the results of a parallel-group cluster-randomized controlled trial evaluating the efficacy of promoting COVID-19...
8.
Wu X, Wu G, Ma P, Wang R, Li L, Chen Y, et al.
Nat Commun
. 2023 Sep;
14(1):5334.
PMID: 37660054
Despite the proven virological advantages, there remains some controversy regarding whether first-line integrase strand transfer inhibitors (INSTIs)-based antiretroviral therapy (ART) contributes to reducing mortality of people living with HIV (PLHIV)...
9.
Wu X, Wu G, Ma P, Wang R, Li L, Sun Y, et al.
Infect Dis Poverty
. 2023 Aug;
12(1):73.
PMID: 37580822
Background: In 2003, China implemented free antiretroviral therapy (ART) for people living with HIV (PLHIV), establishing an eligibility threshold of CD4 < 200 cells/μl. Subsequently, the entry criteria were revised...
10.
Fu L, Sun Y, Li Y, Wang B, Yang L, Tian T, et al.
Vaccines (Basel)
. 2023 Mar;
11(3).
PMID: 36992114
Background: Men who have sex with men (MSM) living with HIV make up the majority of cases in the current Mpox outbreak. We aimed to investigate the perception of and...